Pre-clinical toxicology of AAV2/5-OPTIRPE65, an optimised RPE65 gene therapy vector

被引：0
|
作者：
Georgiadis, A. [1 ,3 ]
Duran, Y. [1 ]
Ribeiro, J. [1 ]
Abelleira, L. [1 ]
Naylor, S. [3 ]
Smith, A. J. [1 ,3 ]
Bainbridge, J. W. B. [1 ,2 ,3 ]
Ali, R. R. [1 ,2 ,3 ]
机构：
[1] UCL Inst Ophthalmol, London, England
[2] Moorfields Eye Hosp, NIHR Biomed Res Ctr, London, England
[3] MeiraGTx Ltd, London, England
来源：
HUMAN GENE THERAPY | 2017年 / 28卷 / 12期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
P220
引用
收藏
页码：A77 / A77
页数：1
相关论文
共 34 条
  • [21] Self-complementary AAV-mediated gene therapy restores cone function and prevents cone degeneration in two models of Rpe65 deficiency
    Pang, J.
    Boye, S. E.
    Lei, B.
    Boye, S. L.
    Everhart, D.
    Ryals, R.
    Umino, Y.
    Rohrer, B.
    Alexander, J.
    Li, J.
    Dai, X.
    Li, Q.
    Chang, B.
    Barlow, R.
    Hauswirth, W. W.
    GENE THERAPY, 2010, 17 (07) : 815 - 826
  • [22] Clinical variability of patients associated with gene mutations of visual cycle protein, arrestin, RPE65 and RDH5 genes
    Wada, Y
    Nakazawa, M
    Abe, T
    Fuse, N
    Tamai, M
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2000, 41 (04) : S617 - S617
  • [23] Proteomic Analysis Following AAV-Mediated Gene Therapy in rd12 Mice, a Model of Leber Congenital Amaurosis With Rpe65 Mutation
    Zheng, Q.
    Li, W.
    Chen, G.
    Li, M.
    Luo, X.
    Kong, F.
    Hauswirth, W. W.
    Qu, J.
    Pang, J. J.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [24] Pre-clinical evaluation of AAV5-miHTT gene therapy of Huntington's disease
    Miniarikova, J.
    Zanella, I.
    Blits, B.
    Zimmer, V.
    Spoerl, A.
    Southwell, A.
    Hayden, M.
    Deventer, S. V.
    Deglon, N.
    Petry, H.
    Konstantinova, P.
    HUMAN GENE THERAPY, 2015, 26 (10) : A11 - A11
  • [25] PRE-CLINICAL EVALUATION OF AAV5-MIHTT GENE THERAPY OF HUNTINGTON'S DISEASE IN RODENTS
    Miniarikova, Jana
    Zanella, Ilaria
    Blits, Bas
    Evers, Melvin
    Zimmer, Virginie
    Spoerl, Alexia
    Southwell, Amber
    Hayden, Michael
    van Deventer, Sander
    Deglon, Nicole
    Petry, Harald
    Konstantinova, Pavlina
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2016, 87 : A91 - A92
  • [26] Single Center Experience with Voretigene Neparvovec Gene Augmentation Therapy in RPE65 Mutation-Associated Inherited Retinal Degeneration in a Clinical Setting
    Lorenz, Birgit
    Kuenzel, Sandrine H.
    Preising, Markus N.
    Scholz, Johanna P.
    Chang, Petrus
    Holz, Frank G.
    Herrmann, Philipp
    OPHTHALMOLOGY, 2024, 131 (02) : 161 - 178
  • [27] The Role of the Human Visual Cortex in Assessment of the Long-Term Durability of Retinal Gene Therapy in Follow-on RPE65 Clinical Trial Patients
    Ashtari, Manzar
    Nikonova, Elena S.
    Marshall, Kathleen A.
    Young, Gloria J.
    Aravand, Puya
    Pan, Wei
    Ying, Gui-shuang
    Willett, Aimee E.
    Mahmoudian, Mani
    Maguire, Albert M.
    Bennett, Jean
    OPHTHALMOLOGY, 2017, 124 (06) : 873 - 883
  • [28] Pre-clinical efficacy testing of AAV-based gene therapy for KCNV2-deficiency
    Carvalho, Livia
    Rashwan, Rabab
    Lim, Xin Ru
    Brunet, Alicia
    Miller, Annie Laura
    Bhatt, Yashvi
    Fuller-Carter, Paula
    Hunt, David
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [29] Gene therapy in 6 dogs with RPE65 null mutation improves visual function:: A short-term study using clinical observations.: Electophysiology and morphology
    Narfstrom, K
    Bragadòttir, R
    Redmond, TM
    Katz, ML
    Lei, B
    Lai, CM
    Rakoczy, EP
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2002, 43 : U1307 - U1307
  • [30] Pre-clinical study of RM-101, a novel AAV-based gene therapy for USH2A-related Retinitis Pigmentosa
    Ou, Jiayu
    Tu, Jiaqi
    Zhang, Hong
    Wu, Kun
    Li, Yan
    Xu, Hui
    Xiao, Zhendong
    Huang, Junjiu
    Liang, Junbin
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
1234